Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2018

01-07-2018 | Review Article

Perspectives on diagnosis and management of adult idiopathic intracranial hypertension

Authors: Irini Chatziralli, Panagiotis Theodossiadis, George Theodossiadis, Ioannis Asproudis

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 7/2018

Login to get access

Abstract

Purpose

The purpose of this review is to shed light into the diagnostic challenges regarding idiopathic intracranial hypertension (IIH), giving more emphasis to the role of optical coherence tomography (OCT) in IIH, while it also presents recent advances in the management of IIH.

Methods

A literature search in PubMed was performed for studies about the diagnosis and management of IIH published before June 30, 2017. Then, a comprehensive review of the eligible studies and the relevant references was performed.

Results

Apart from the updated modified criteria, OCT has been found to be important for the diagnosis of IIH, along with assessment of clinical signs and symptoms, brain imaging, and lumbar puncture. On the other hand, there is no current consensus for the management of IIH, but various interventions have been used, such as dietary therapy (weight loss, bariatric surgery, lifestyle modification, low-salt diet), medications, and surgical treatment.

Conclusions

IIH is a challenging and serious disorder, which may lead to permanent visual impairment if there is a delay in its diagnosis. Advances in retinal imaging have led to better understanding of the pathogenesis of the disease and prompt diagnosis even in subtle cases can be done using OCT. Surgical interventions should be minimized and only used in cases refractory to medical treatment and in those with rapid progression.
Literature
1.
Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81:1159–1165CrossRefPubMed
2.
Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18:1266–1268CrossRefPubMed
3.
Craig JJ, Mulholland DA, Gibson JM (2001) Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991–1995). Ulster Med J 70:31–35PubMedPubMedCentral
4.
Kesler A, Stolovic N, Bluednikov Y, Shohat T (2014) The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol 21:1055–1059CrossRefPubMed
5.
Markey KA, Mollan SP, Jensen RH, Sinclair AJ (2016) Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 15:78–91CrossRefPubMed
6.
Donaldson JO (1979) Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc 104:196–198PubMed
7.
Malm J, Kristensen B, Markgren P, Ekstedt J (1992) CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study. Neurology 42:851–858CrossRefPubMed
8.
Johnston I (1973) Reduced CSF absorption syndrome: reappraisal of benign intracranial hypertension and related conditions. Lancet 2:418–421CrossRefPubMed
9.
Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ, Biousse V (2013) Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 80:289–295CrossRefPubMedPubMedCentral
10.
Hannerz J, Ericson K (2009) The relationship between idiopathic intracranial hypertension and obesity. Headache 49:178–184CrossRefPubMed
11.
Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT (2011) Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 76:1564–1567CrossRefPubMed
12.
Samancı B, Samancı Y, Tüzün E, Altıokka-Uzun G, Ekizoğlu E, İçöz S, Şahin E, Küçükali CI, Baykan B (2017) Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension. Cephalalgia 37:525–531CrossRefPubMed
13.
Dhungana S, Sharrack B, Woodroofe N (2009) Cytokines and chemokines in idiopathic intracranial hypertension. Headache 49:282–285CrossRefPubMed
14.
Killer HE, Jaggi GP, Miller NR (2011) Optic nerve compartment syndrome. Acta Ophthalmol 89:472CrossRef
15.
Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR, Mironov A (2007) Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional? Brain 130:514–520CrossRefPubMed
16.
Killer HE, Jaggi GP, Miller NR (2009) Papilledema revisited: is its pathophysiology really understood? Clin Exp Ophthalmol 37:444–447CrossRefPubMed
17.
Coker JG, Duker JS (1996) Macular disease and optical coherence tomography. Curr Opin Ophthalmol 7:33–38CrossRefPubMed
18.
Stanga PE, Bird AC (2001) Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Int Ophthalmol 23:191–197CrossRefPubMed
19.
Satue M, Obis J, Rodrigo MJ, Otin S, Fuertes MI, Vilades E, Gracia H, Ara JR, Alarcia R, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E (2016) Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases. J Ophthalmol 2016:8503859CrossRefPubMedPubMedCentral
20.
Nolan RC, Narayana K, Galetta SL, Balcer LJ (2015) Optical coherence tomography for the neurologist. Semin Neurol 35:564–577CrossRefPubMed
21.
22.
Heidary G, Rizzo JF 3rd (2010) Use of optical coherence tomography to evaluate papilledema and pseudopapilledema. Semin Ophthalmol 25:198–205CrossRefPubMed
23.
Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495CrossRefPubMed
24.
Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808CrossRef
25.
Yri HM, Rönnbäck C, Wegener M, Hamann S, Jensen RH (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21:1458–1464CrossRefPubMed
26.
Amico D D, Curone M, Ciasca P, Cammarata G, Melzi L, Bussone G, Bianchi Marzoli S (2013) Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci 34(Suppl 1):S147–S149CrossRef
27.
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701CrossRefPubMedPubMedCentral
28.
Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180PubMed
29.
Sadun AA, Currie JN, Lessell S (1984) Transient visual obscurations with elevated optic discs. Ann Neurol 16:489–494CrossRefPubMed
30.
Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V (2015) Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol 35:31–36CrossRefPubMedPubMedCentral
31.
Wall M, White WN 2nd (1998) Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 39:134–142PubMed
32.
33.
Sinclair AJ, Burdon MA, Nightingale PG, Matthews TD, Jacks A, Lawden M, Sivaguru A, Gaskin B, Rauz S, Clarke CE, Ball AK (2012) Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J Neurol 259:1406–1412CrossRefPubMed
34.
Thambisetty M, Lavin PJ, Newman NJ, Biousse V (2007) Fulminant idiopathic intracranial hypertension. Neurology 68:229–232CrossRefPubMed
35.
Best J, Silvestri G, Burton B, Foot B, Acheson J (2013) The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J 7:26–29CrossRefPubMedPubMedCentral
36.
Pollak L, Zohar E, Glovinsky Y, Huna-Baron R (2013) Reevaluation of presentation and course of idiopathic intracranial hypertension—a large cohort comprehensive study. Acta Neurol Scand 127:406–412CrossRefPubMed
37.
Mollan SP, Markey KA, Benzimra JD, Jacks A, Matthews TD, Burdon MA, Sinclair AJ (2014) A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol 14:380–390CrossRefPubMedPubMedCentral
38.
39.
Bäuerle J, Nedelmann M (2011) Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension. J Neurol 258:2014–2019CrossRefPubMed
40.
Lam BL, Morais CG Jr, Pasol J (2008) Drusen of the optic disc. Curr Neurol Neurosci Rep 8:404–408CrossRefPubMed
41.
Scott CJ, Kardon RH, Lee AG, Frisén L, Wall M (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705–711CrossRefPubMed
42.
Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R (2013) Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 251:567–574CrossRefPubMed
43.
Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D'Amico D (2013) Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis. Neurol Sci 34(Suppl 1):S143–S145CrossRefPubMed
44.
OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci 55:8180–8188CrossRef
45.
Waisbourd M, Leibovitch I, Goldenberg D, Kesler A (2011) OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113:839–843CrossRefPubMed
46.
Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP (2015) OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg 130:122–127CrossRefPubMed
47.
Yri HM, Wegener M, Sander B, Jensen R (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259:886–894CrossRefPubMed
48.
Skau M, Sander B, Milea D, Jensen R (2011) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 258:277–283CrossRefPubMed
49.
Wang JK, Kardon RH, Ledolter J, Sibony PA, Kupersmith MJ, Garvin MK, OCT Sub-Study Committee and the NORDIC Idiopathic Intracranial Hypertension Study Group (2017) Peripapillary retinal pigment epithelium layer shape changes from acetazolamide treatment in the idiopathic intracranial hypertension treatment trial. Invest Ophthalmol Vis Sci 58:2554–2565CrossRefPubMedPubMedCentral
50.
51.
52.
Bidot S, Saindane AM, Peragallo JH, Bruce BB, Newman NJ, Biousse V (2015) Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol 35:400–411CrossRefPubMed
53.
Chang RO, Marshall BK, Yahyavi N, Sharma A, Huecker J, Gordon MO, McClelland C, Van Stavern GP (2016) Neuroimaging features of idiopathic intracranial hypertension persist after resolution of papilloedema. Neuroophthalmology 40:165–170CrossRefPubMedPubMedCentral
54.
Biousse V (2012) Idiopathic intracranial hypertension: diagnosis, monitoring and treatment. Rev Neurol (Paris) 168:673–683CrossRef
55.
56.
57.
Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M (1998) Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50:1094–1098CrossRefPubMed
58.
Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701CrossRefPubMedPubMedCentral
59.
Subramaniam S, Fletcher WA (2017) Obesity and weight loss in idiopathic intracranial hypertension: anarrative review. J Neuroophthalmol 37:197–205CrossRefPubMed
60.
Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D (2011) Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 114:34–39CrossRefPubMed
61.
Sugerman HJ, Felton WL 3rd, Salvant JB Jr, Sismanis A, Kellum JM (1995) Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 45:1655–1659CrossRefPubMed
62.
Levin AA, Hess D, Hohler AD (2015) Treatment of idiopathic intracranial hypertension with gastric bypass surgery. Int J Neurosci 125:78–80CrossRefPubMed
63.
Manfield JH, Yu KK, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H (2017) Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg 27:513–521CrossRefPubMed
64.
Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies MB, Sinclair AJ, Clarke CE (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258:874–881CrossRefPubMed
65.
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311:1641–1651CrossRef
66.
Celebisoy N, Gökçay F, Sirin H, Akyürekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327CrossRefPubMed
67.
McCarthy KD, Reed DJ (1974) The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 189:194–201PubMed
68.
Satti SR, Leishangthem L, Chaudry MI (2015) Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 36:1899–1904CrossRefPubMed
69.
Starks V, Gilliland G, Vrcek I, Gilliland C (2016) Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness. Orbit 35:87–90CrossRefPubMed
70.
Obi EE, Lakhani BK, Burns J, Sampath R (2015) Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary centre. Clin Neurol Neurosurg 137:94–101CrossRefPubMed
71.
Pineles SL, Volpe NJ (2013) Long-term results of optic nerve sheath fenestration for idiopathic intracranial hypertension: earlier intervention favours improved outcomes. Neuroophthalmology 37:12–19CrossRefPubMedPubMedCentral
72.
Tarrats L, Hernández G, Busquets JM, Portela JC, Serrano LA, González-Sepúlveda L, Sánchez-Pérez JR (2017) Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension. Int Forum Allergy Rhinol 7:615–623CrossRefPubMedPubMedCentral
73.
Fonseca PL, Rigamonti D, Miller NR, Subramanian PS (2014) Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol 98:1360–1363CrossRefPubMed
74.
Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G (2011) Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 31:1627–1633CrossRefPubMed
75.
Teleb MS, Cziep ME, Issa M, Lazzaro M, Asif K, Hong SH, Lynch JR, Fitzsimmons BF, Remler BF, Zaidat OO (2015) Stenting and angioplasty for idiopathic intracranial hypertension: a case series with clinical, angiographic, ophthalmological, complication, and pressure reporting. J Neuroimaging 25:72–80CrossRefPubMed
76.
Teleb MS, Cziep ME, Lazzaro MA, Gheith A, Asif K, Remler B, Zaidat OO (2013) Idiopathic intracranial hypertension. A systematic analysis of transverse sinus stenting. Interv Neurol 2:132–143CrossRefPubMed
77.
De Simone R, Marano E, Fiorillo C, Briganti F, Di Salle F, Volpe A, Bonavita V (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 25:342–344CrossRefPubMed
Metadata
Title
Perspectives on diagnosis and management of adult idiopathic intracranial hypertension
Authors
Irini Chatziralli
Panagiotis Theodossiadis
George Theodossiadis
Ioannis Asproudis
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 7/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3970-4

Other articles of this Issue 7/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2018 Go to the issue

Retinal Disorders

Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy

Glaucoma

Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index

Oncology

Features of choroidal naevi on swept source optical coherence tomography angiography and structural reverse flow optical coherence tomography

Basic Science

Outflow enhancement by three different ab interno trabeculectomy procedures in a porcine anterior segment model

Trauma

Clinical characteristics and outcomes of fall-related open globe injuries in Japan

Pediatrics

The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats’ disease